Consequently, the overexpression of mutant IDH1 or D2HG sensitizes glioma cells to infection by oncolytic viruses such as VSVΔ51, thereby promoting viral replication and enhancing therapeutic efficacy [78]. The gene discussed is IDH1; the disease is glioma.